BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31629472)

  • 21. Deletion of the Feeding-Induced Hepatokine TSK Ameliorates the Melanocortin Obesity Syndrome.
    Wang Q; Zhang P; Cakir I; Mi L; Cone RD; Lin JD
    Diabetes; 2021 Sep; 70(9):2081-2091. PubMed ID: 34183373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
    Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
    BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
    J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential metabolic and hepatic transcriptome responses of two miniature pig breeds to high dietary cholesterol.
    Cai Z; Yu C; Fu D; Pan Y; Huang J; Rong Y; Deng L; Chen J; Chen M
    Life Sci; 2020 Jun; 250():117514. PubMed ID: 32145306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
    Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
    Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake.
    van den Berg SA; Heemskerk MM; Geerling JJ; van Klinken JB; Schaap FG; Bijland S; Berbée JF; van Harmelen VJ; Pronk AC; Schreurs M; Havekes LM; Rensen PC; van Dijk KW
    FASEB J; 2013 Aug; 27(8):3354-62. PubMed ID: 23650188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis.
    Akiyama K; Warabi E; Okada K; Yanagawa T; Ishii T; Kose K; Tokushige K; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Ariizumi SI; Yamamoto M; Shoda J
    Exp Anim; 2018 May; 67(2):201-218. PubMed ID: 29276215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
    Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
    J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs.
    Yang SL; Xia JH; Zhang YY; Fan JG; Wang H; Yuan J; Zhao ZZ; Pan Q; Mu YL; Xin LL; Chen YX; Li K
    Sci Rep; 2015 Sep; 5():13980. PubMed ID: 26358367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review.
    Valette M; Bellisle F; Carette C; Poitou C; Dubern B; Paradis G; Hercberg S; Muzard L; Clément K; Czernichow S
    Int J Obes (Lond); 2013 Aug; 37(8):1027-35. PubMed ID: 23147118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis.
    Komiya C; Tanaka M; Tsuchiya K; Shimazu N; Mori K; Furuke S; Miyachi Y; Shiba K; Yamaguchi S; Ikeda K; Ochi K; Nakabayashi K; Hata KI; Itoh M; Suganami T; Ogawa Y
    Sci Rep; 2017 Mar; 7():44754. PubMed ID: 28303974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficient melanocortin-4 receptor causes abnormal reproductive neuroendocrine profile in female mice.
    Chen X; Huang L; Tan HY; Li H; Wan Y; Cowley M; Veldhuis JD; Chen C
    Reproduction; 2017 Mar; 153(3):267-276. PubMed ID: 28003536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group VIA phospholipase A2 deficiency in mice chronically fed with high-fat-diet attenuates hepatic steatosis by correcting a defect of phospholipid remodeling.
    Otto AC; Gan-Schreier H; Zhu X; Tuma-Kellner S; Staffer S; Ganzha A; Liebisch G; Chamulitrat W
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):662-676. PubMed ID: 30735855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes.
    Zhu X; Gan-Schreier H; Otto AC; Cheng Y; Staffer S; Tuma-Kellner S; Ganzha A; Liebisch G; Chamulitrat W
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):677-687. PubMed ID: 30735854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
    Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.